UBS Group’s Healthcare Triangle HCTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$82.4K Buy
5,738
+5,295
+1,195% +$126K ﹤0.01% 7280
2026
Q2
$16K Sell
443
-1,593
-78% -$73.6K ﹤0.01% 8296
2026
Q1
$110K Buy
2,036
+2,030
+33,833% +$494K ﹤0.01% 6965
2025
Q4
$4.82K Sell
6
-5
-45% -$13.9K ﹤0.01% 8774
2025
Q3
$35.9K Buy
+11
New +$57.8K ﹤0.01% 7786
2025
Q2
– Hold
0
– – – 9801
2025
Q1
– Hold
0
– – – 9505
2024
Q4
– Hold
0
– -$58K – 10120
2024
Q3
– Hold
0
– – – 6720
2024
Q2
– Hold
0
– – – 7892
2024
Q1
– Hold
0
– -$1.88K – 9607
2023
Q4
– Hold
0
– – – 8202
2023
Q3
– Hold
0
– – – 7666
2023
Q2
– Hold
0
– – – 7129
2023
Q1
– Hold
0
– – – 7545
2022
Q4
– Hold
0
– – – 8850
2022
Q3
– Hold
0
– -$14K – 10571
2022
Q2
– Hold
0
– – – 7400
2022
Q1
– Hold
0
– -$12K – 10506
2021
Q4
– Hold
0
– – – 8556

Other funds holding HCTI

UBS Group's HCTI Position: Q3 2026 in Review

UBS Group increased its Healthcare Triangle (HCTI) stake by 1,195% in Q3 2026, buying an estimated $126K and bringing the position to 5,738 shares worth $82.4K. The position accounts for ﹤0.01% of the portfolio, ranked #7280.

UBS Group first reported a position in HCTI in Q3 2025 and has held it in 5 quarters since. The position peaked at $110K in Q1 2026. 7 funds tracked by Wall St. Rank hold HCTI as of Q3 2026.

  • UBS Group held 5,738 shares of Healthcare Triangle worth $82.4K as of Q3 2026.
  • UBS Group bought 5,295 Healthcare Triangle shares in Q3 2026, an estimated $126K.
  • Healthcare Triangle made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #7280 holding.
  • UBS Group first reported a position in Healthcare Triangle in Q3 2025 and has held it in 5 quarters since.
  • UBS Group's Healthcare Triangle position peaked at $110K in Q1 2026.
  • 7 funds tracked by Wall St. Rank held Healthcare Triangle as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.